Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 837, Issue 1-2, 2006, Pages 1-10

  Cooper, Nancy ^a   Khosravan, Reza ^b   Erdmann, Carol ^a   Fiene, John ^a   Lee, Jean W ^a  

^a MDS Inc   (Canada)

^b TAP PHARMACEUTICAL PRODUCTS INC   (United States)

Author keywords

HPLC; Human serum; Pharmacodynamic biomarkers; Uric acid; Xanthine oxidase inhibitor

Indexed keywords

BIOMARKERS; BODY FLUIDS; CONCENTRATION (PROCESS); HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; PHARMACODYNAMICS; PROTEINS;

HUMAN SERUM; PHARMACODYNAMIC BIOMARKERS; URIC ACID; XANTHINE OXIDASE INHIBITOR;

AMINO ACIDS;

BIOLOGICAL MARKER; BUFFER; FEBUXOSTAT; HYPOXANTHINE; PHOSPHATE; URIC ACID; XANTHINE; XANTHINE OXIDASE INHIBITOR;

ACCURACY; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA ANALYSIS; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROPHILICITY; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY ANALYSIS; ULTRAFILTRATION; URIC ACID BLOOD LEVEL; VALIDATION STUDY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; HUMANS; HYPOXANTHINE; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URIC ACID; XANTHINE; XANTHINE OXIDASE;

EID: 33747046752     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.02.060     Document Type: Article

References (50)

1. Stirpe F., and Della C.E. J. Biol. Chem. 244 (1969) 3855
2. Della C.E., and Stirpe F. FEBS Lett. 2 (1968) 83
3. Della C.E., and Stirpe F. Biochem. J. 126 (1972) 739
4. Battelli M.G. FEBS Lett. 113 (1980) 47
5. Moriwaki Y., Yamamoto T., Suda M., Nasako Y., Takahashi S., and Agbedana O.E. Biochem. Biophys. Acta 1164 (1993) 327
6. Hille R. Chem. Rev. 96 (1996) 2757
7. Yokoyama Y., Beckman J.S., Beckman T.K., Wheat J.K., Cash T.G., and Freeman B.A. Am. J. Physiol. 258 (1990) G564
8. Müller M.J., Vollmar B., Friedl H.P., and Manger M.D. Free Rad. Biol. Med. 21 (1996) 189
9. Petrone W.F., English D.K., Wong K., and McCord J.M. Proc. Natl. Acad. Sci. USA 77 (1980) 1159
10. Suzuki M., Grisham M.B., and Granger D.N. J. Leukocyte Biol. 50 (1991) 488
11. Shenkar R., and Abraham E. Am. J. Respir. Cell Mol. Biol. 14 (1996) 198
12. Rao G.N., Corson M.A., and Berk C.B. J. Biol. Chem. 266 (1991) 8604
13. Boogaerts M.A., Hammerschmidt D.E., Roelant C., Verwilghen R.L., and Jacob H.S. Thromb. Haemostas. 50 (1983) 576
14. Swain J., and Guteridge J.M.C. FEBS Lett. 368 (1995) 513
15. Patetsios P., Song M., Shutze W.P., Pappas C., Rodina W., Ramirez J.A., and Panetta T.F. Am. J. Card. 88 (2001) 188
16. F.D.A. Mar 2004 report, Innovation or Stagnation? Challenge and opportunity on the critical path to new medical products, available at http://www.fda.gov/oc/initiatives/critical path/.
17. Food and Drug Administration: Guidance for industry, Exposure-response relationships-study design, data analysis, and regulatory applications, CDER and CBER, April 2003.
18. Yamamoto T., Moriwaki Y., Takahashi S., Tsutsumi Z., Yamakita J., and Nasako Y. J. Chromatogr. B 681 (1996) 395
19. Xia Y., and Zweier J.L. J. Biol. Chem. 270 (1995) 18797
20. Xia Y., Khatchikian G., and Zweier J.L. J. Biol. Chem. 271 (1996) 10096
21. Buonocore G., Perrone S., Longini M., Terzuoli L., and Bracci R. Pediatr. Res. 4 (2000) 221
22. Al-Khalidi U., Nasrallah S., Khachadurian A.K., and Shammaa M.H. Clin. Chem. Acta 11 (1965) 72
23. McHale A., Grimes H., and Coughlan M.P. Int. J. Biochem. 10 (1979) 317
24. Beckman J.S., Parks D.A., Pearson J.D., Marshall P.A., and Freeman B.A. Free Radic. Biol. Med. 6 (1989) 607
25. Battelli M.G., Abbondanza A., Musiani S., Buonamici L., Strocchi P., and Tazzari P.L. Clin. Chem. Acta 281 (1999) 47
26. Atlante A., Valenti D., Gagliardi S., and Passarella S. Brain Res. Prococols 6 (2000) 1
27. Kock R., Delvoux B., and Greiling H. Eur. J. Clin. Chem. Clin. Biochem. 31 (1993) 303
28. Czauderna M., and Kowalczyk J. J. Chromatogr. B 704 (1997) 89
29. Sumi S., Kidouchi K., Ohba S., and Wada Y. J. Med. Tech. 39 (1995) 485
30. Czauderna M., and Kowalczyk J. J. Chromatogr. B 744 (2000) 129
31. Velazquez F.R., Altaffer M., Philipp K., and Upham S. Clin. Chem. 40 (1994) 1094
32. Pundir C.S., Bhargava A.K., and Harb L. J. Biochem. Biophy. Methods 39 (1999) 125
33. Song Z.H., and Hou S. Anal. Bioanal. Chem. 372 (2002) 327
34. Tsai H.C., and Doong R.A. Anal. Biochem. 334 (2004) 183
35. Lee J.W., Nordblom G.D., Smith W.C., and Bowsher R.R. In: Bloom J. (Ed). Biomarkers in Clinical Drug Development (2003), Marcel Dekker, New York 119
36. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., and Yacobi A. J. Pharm. Sci. 9 (1992) 588
37. Lee J.W., Hulse J.D., and Colburn W.A. J. Clin. Pharmacol. 35 (1995) 464
38. Shah V.P., Midha K.K., Findlay J.W.A., Hill H.M., Hulse J.D., and McGilvary I.J. Pharm. Res. 17 (2000) 1551
39. Food and Drug Administration: Guidance for Industry Bioanalytical Method Validation, CDER, 2001.
40. Lee J.W., Weiner R.S., Sailstad J.M., Bowsher R.R., Knuth D.W., and O'Brien P.J. Pharm. Res. 22 (2005) 499
41. Miller K.J., Bowsher R.R., Celniker A., Gibbons J., Gupta S., and Lee J.W. Pharm. Res. 18 (2001) 1373
42. Findlay J.W.A., Smith W.C., Lee J.W., Nordblom G.D., Das I., and DeSilva B.S. J. Pharm. Biomed. Anal. 21 (2000) 1249
43. Lee J.W., Devanarayan V., Barrett Y.C., Allinson J., Fountain S., and Keller S. Pharm. Res. Accept. (2005)
44. Li Z., Rutan S.C., and Dong S. Anal. Chem. 68 (1996) 124
45. Al-Alaiyan S., Al-Rauithi S., Raines D., Yusuf A., Legayada E., and Shoukri M.M. J. Clin. Pharmacol. 41 (2001) 620
46. Grant D.M., Tang B.K., and Kalow W. Clin. Pharmacol. Ther. 33 (1983) 591
47. Callahan M.M., Robertson R.S., Arnaud M.J., Branfman A.R., McComish M.F., and Yesair D.W. Drug Metab. Dispos. 10 (1982) 417
48. Moriwaki Y., Yamamoto T., and Higashino K. Histol. Histopathol. 14 (1999) 1321
49. Mayer M.D., Khosravan R., Vernillet L., Wu J., Joseph-Ridge N., and Mulford D.J. Am. J. Ther. 12 (2005) 22-34
50. Cotran R.S., Kumar V., and Robbins S.L. Robbins Pathologic Basis of Disease. fourth ed. (1989), W.B. Saunders Company, Philadelphia, PA pp. 1355-1360